Clinical Trials

27 enrolled

NSCLC

NCT07044362 2026-03-19

Histotripsy Plus Chemotherapy vs Chemotherapy Alone for Advanced Colorectal Liver Metastasis

100 enrolled

Liver Neoplasms, Colorectal Neoplasms

NCT05941741 2026-03-18

IC Plus Low-dose Radiation Plus Cadonilimab in LANPC

Phase 3 Recruiting

380 enrolled

Nasopharyngeal Carcinoma

NCT03785574 2026-03-16

Study of Different Therapeutic Strategies in Hydatidiform Mole With Lung Nodule

Gynecologic

Hydatidiform Mole, Gestational Trophoblastic Disease

NCT07457528 2026-03-11

Efficacy and Safety of Neo-CRT Plus Serplulimab, Nimotuzumab in Patients With Locally Advanced Resectable ESCC

46 enrolled

Esophageal Squamous Cell Carcinoma

NCT05378334 2026-03-10

Efficacy and Safety of HGXJT in Bone Metastatic NSCLC Patients

82 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06408116 2026-03-10

PEGASUS

Esophageal Neoplasms

NCT07209189 2026-03-09

(NeoScorch HN)

75 enrolled

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms, Papillomavirus Infections

NCT07455019 2026-03-06

A Study of Bemosubaiabimab Combined With Anlotinib and Radiotherapy and Chemotherapy for the Treatment of Oligometastatic Esophageal Cancer

28 enrolled

Esophageal Neoplasms

NCT04575935 2026-03-05

Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial

Phase 3 Recruiting

580 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT07042438 2026-03-05

Fecal Microbiome Transplant to Remodel Intestinal Microbiota for Patients With Relapsed or Refractory Lymphoma With Exposure to High-Risk Antibiotics Who Are Receiving Chimeric Antigen Receptor T Cells

56 enrolled

Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT07452003 2026-03-05

An Exploratory Study of QL1706 Plus Chemotherapy in Perioperative NSCLC

GastrointestinalGynecologic

Carcinoma, Non-Small-Cell Lung

NCT04857528 2026-03-04

Detecting HPV DNA in Anal and Cervical Cancers

Recruiting

20 enrolled

Anus Neoplasms, Uterine Cervical Neoplasms

NCT06177067 2026-03-04

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

Phase 1 Recruiting

24 enrolled

Other hematologic neoplasm

Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute

NCT04703244 2026-03-03

Development of Patient Derived Xenografts (PDX) in Patients With Breast Cancer

Recruiting

999 enrolled

Breast

Breast Neoplasms

NCT06719700 2026-03-03

Concurrent Chemoradiotherapy Combined With Toripalimab and Surufatinib in the Treatment of Limited-Stage Small Cell Lung Cancer

47 enrolled

Small Cell Lung Carcinoma

NCT07447570 2026-03-03

Iparomlimab and Tuvonralimab Plus Hypofractionated Radiotherapy and Chemotherapy for HAHNSCC

27 enrolled

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT07342283 2026-03-02

QL1706 Plus Chemotherapy as Neoadjuvant Therapy in Triple-Negative Breast Cancer

Breast

Triple Negative Breast Neoplasms

NCT07033819 2026-02-27

Neoadjuvant Treatment of Ovarian Cancer With Fuzuloparib in Combination With Apatinib

48 enrolled

Gynecologic

Ovarian Neoplasms

NCT07437898 2026-02-27

Neoadjuvant Adebrelimab Plus Chemotherapy for Esophageal Cancer: A Clinical Study

42 enrolled

Esophageal Squamous Cell Carcinoma

NCT07425795 2026-02-23

Tislelizumab Combined With Chemotherapy Followed by Thoracic Consolidation Radiotherapy in the First-line Treatment of Extensive Stage Small Cell Lung Cancer

36 enrolled

Extensive Stage Small Cell Lung Cancer (ES-SCLC)

NCT06353646 2026-02-13

XH001 Combination With Immunocheckpoint Inhibitor and Chemotherapy for Patients With Resected Pancreatic Cancer

28 enrolled

Pancreatic Neoplasms

NCT07408635 2026-02-13

IBI363 (PD-1/IL-2α-bias) in Combination With Chemotherapy as Neoadjuvant Therapy in Initially Unresectable Stage III Non-Small Cell Lung Cancer

43 enrolled

LymphoidOther hematologic neoplasm

Carcinoma, Carcinoma, Non-Small-Cell Lung

NCT06860269 2026-02-10

GRAALL-2024

Phase 2/3 Recruiting

1,200 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07398937 2026-02-10

ECTOP-1036

116 enrolled

Lung Neoplasms

NCT04297605 2026-02-09

Study of Pembrolizumab and Single Agent Chemotherapy as First Line Treatment for Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer With Eastern Cooperative Oncology Group (ECOG) Performance Status of 2

Phase 1 Recruiting

28 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06610734 2026-02-09

SKY

202 enrolled

Small Cell Lung Cancer Extensive Stage

NCT07162506 2026-02-04

DCRT vs. Surgery in Resectable ESCC Patient Achiving cCR/PR After nCI

120 enrolled

Esophageal Neoplasms

NCT06627712 2026-01-30

SBRT Combined With PD-1 Inhibitor and Chemotherapy in Early-stage TNBC

Phase 3 Recruiting

318 enrolled

Breast

Triple Negative Breast Neoplasms

NCT04643366 2026-01-27

Total Neoadjuvant Therapy With mFOLFOX and Short-course Radiation in Resectable Rectal Cancer

54 enrolled

Rectal Neoplasms

NCT06997094 2026-01-26

Decitabine in Combination With Standard of Care Therapy for the Treatment of Surgically Resectable HPV-Negative Head and Neck Cancer

Phase 1 Recruiting

24 enrolled

Human Papillomavirus-Negative Neck Squamous Cell Carcinoma

NCT07188532 2026-01-23

BEAR